尽情期待！2022 中华医学会卫星会邀您共话生殖热点

中华医学会第十五次全国生殖医学学术会议将于 8 月 3 日-7 日在美丽的海滨城市厦门举行，雅培展台将于 8 月 5 日-7 日在厦门国际会展中心 C2 厅 L-04 进行展出。

LOTUS 系列研究都指出：地屈孕酮的持续妊娠率及活产率 不劣于，甚至有可能要优于传统使用的阴道用黄体酮，口服的给药方式可能会给与患者更高的满意度。

1.Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod2017;32:1019–27.

2.Griesinger G, Blockeel C, Sukhikh G, et al. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Hum Reprod. 2018;33(12):2212-2221.

3.Griesinger G, Blockeel C, Kahler E, et al. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis. PLoS One. 2020 Nov 4;15(11):e0241044.

4.Ozer G, Yuksel B, YucelCicek OS, Kahraman S. Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients. J GynecolObstet Hum Reprod. 2021;50(5):102030.